Evidence map›Paper›PMID 27798376›Full record

ArticleClinical trials (London, England)2017

Leveraging contact network structure in the design of cluster randomized trials.

Guy Harling, Rui Wang, Jukka-Pekka Onnela, Victor De Gruttola

Abstract read
In one paragraph

Article in Clinical trials (London, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Causal Inference for Social Network Data.Journal of the American Statistical Association · 2024
    Article
  3. A Network Approach to Stroke Systems of Care.Circulation. Cardiovascular quality and outcomes · 2019
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Guy Harling1 Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Rui Wang2 Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Jukka-Pekka Onnela2 Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Victor De Gruttola2 Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Funding

Methods to Advance the HIV Prevention Research AgendaR37AI051164 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI DEGRUTTOLA, VICTOR GERARD · 2012 to 2019
$3.3M
STATISTICAL METHODS IN AIDS RESEARCHR01AI024643 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI HUGHES, MICHAEL DAVID · 1987 to 2014
$1.7M
NIAID NIH HHS R01 AI024643NIAID NIH HHS R37 AI051164
6 · The paper itself

Abstract

backgroundIn settings like the Ebola epidemic, where proof-of-principle trials have provided evidence of efficacy but questions remain about the effectiveness of different possible modes of implementation, it may be useful to conduct trials that not only generate information about intervention effects but also themselves provide public health benefit. Cluster randomized trials are of particular value for infectious disease prevention research by virtue of their ability to capture both direct and indirect effects of intervention, the latter of which depends heavily on the nature of contact networks within and across clusters. By leveraging information about these networks-in particular the degree of connection across randomized units, which can be obtained at study baseline-we propose a novel class of connectivity-informed cluster trial designs that aim both to improve public health impact (speed of epidemic control) and to preserve the ability to detect intervention effects.

methodsWe several designs for cluster randomized trials with staggered enrollment, in each of which the order of enrollment is based on the total number of ties (contacts) from individuals within a cluster to individuals in other clusters. Our designs can accommodate connectivity based either on the total number of external connections at baseline or on connections only to areas yet to receive the intervention. We further consider a "holdback" version of the designs in which control clusters are held back from re-randomization for some time interval. We investigate the performance of these designs in terms of epidemic control outcomes (time to end of epidemic and cumulative incidence) and power to detect intervention effect, by simulating vaccination trials during an SEIR-type epidemic outbreak using a network-structured agent-based model. We compare results to those of a traditional Stepped Wedge trial.

resultsIn our simulation studies, connectivity-informed designs lead to a 20% reduction in cumulative incidence compared to comparable traditional study designs, but have little impact on epidemic length. Power to detect intervention effect is reduced in all connectivity-informed designs, but "holdback" versions provide power that is very close to that of a traditional Stepped Wedge approach.

conclusionIncorporating information about cluster connectivity in the design of cluster randomized trials can increase their public health impact, especially in acute outbreak settings. Using this information helps control outbreaks-by minimizing the number of cross-cluster infections-with very modest cost in terms of power to detect effectiveness.

Indexed as

Public HealthRandomized Controlled Trials as TopicResearch DesignComputer SimulationDisease OutbreaksEbola VaccinesHemorrhagic Fever, EbolaHumansTime FactorsEbola Vaccinescluster randomized trialEbolaepidemic controlnetworkpowerVaccine

Identifiers

PMID27798376
PMCPMC5300908

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.